Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Invested Capital (2023 - 2026)

Updated

Apimeds Pharmaceuticals US's Invested Capital was $115.36 million in Q2 2026.

Analysis

Apimeds Pharmaceuticals US (APUS) Invested Capital (2023 - 2026) Analysis & Trends

For FY2025, Invested Capital at Apimeds Pharmaceuticals US came in at $160.44 million.

  • In earlier years, Invested Capital was -$1.11 million in FY2024 and $298,760 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Invested Capital since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 134.01 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 64.89 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 82.72 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 38.08 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 148.69 Bn
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - 120.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 120.36 Mn
Dec 31, 2025 160.44 Mn
Mar 31, 2025 -1.14 Mn
Dec 31, 2024 -1.11 Mn
Dec 31, 2023 298,760.00
API Access

Apimeds Pharmaceuticals US Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=APUS&period=max&api_key=YOUR_API_KEY